课题基金 / 基金详情

PEMF Efficacy in Reducing Rheumatoid Arthritis Symptoms

PEMF Efficacy in Reducing Rheumatoid Arthritis Symptoms
PEMF 减轻类风湿关节炎症状的功效
批准号:
6949013
负责人:
CHERYL M BOURGUIGNON
金额:
$19.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-15 至 2007-07-31

项目摘要

项目成果

CHERYL M BOURGUIGNON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is a destructive inflammatory disease with increased mortality and high morbidity, affecting more women than men. The RA symptoms of pain, fatigue, sleep disturbances, and depression often become worse for women during menopause. These symptoms frequently persist in spite of the use of non-steroidal anti-inflammatory drugs and disease modifying anti-rheumatic drugs. In two uncontrolled studies, persons with RA reported improvements in pain and joint swelling after using low strength pulsed electromagnetic fields (PEMF). Thus, the specific aims of this revised exploratory study are to investigate the magnitude of effects of low strength PEMF on reducing the symptoms of pain, fatigue, sleep disturbances, and depression as well as physiologic factors in postmenopausal women with RA; and to test the feasibility of the proposed design. Participants will be randomly assigned to one of three treatment groups: active PEMF, sham PEMF, and standard care. Women in the active and sham PEMF groups will lie on a pad for 8 minutes twice a day. The active group will receive low strength PEMF over the entire body. The sham pad will look and function identically to the active pad, except that no PEMF will be delivered. All participants will remain on their RA medications. Data will be collected at baseline and during the 12 week treatment period. Participants will record data on pain, fatigue, sleep, depression, inflammatory disease activity, perceived stress, and functional status over one 24-hour period during baseline, weeks 1-8, and week 12. At baseline, 6, and 12 weeks, participants will have objective measurements of: sleep disturbances using wrist actigraphy; neuroendocrine/ANS factors (norepinephrine, epinephrine, and cortisol) using both serum and overnight urines; inflammation related measures (IL-1 beta, IL-6, erythrocyte sedimentation rate, C-reactive protein, and rheumatologist joint counts). Women in the active and sham PEMF groups will also record their daily intervention use. Descriptive statistics and mixed effects models will be used to conduct the analysis of the aims.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PULSED ELECTROMAGNETIC FIELD EFFICACY IN REDUCING RHEUMATOID ARTHRITIS SYMPTOMS
  • 批准号:
    7718543
  • 项目类别:
  • 资助金额:
    $0.26万
  • 财政年份:
    2008
  • 负责人:
    CHERYL M BOURGUIGNON
  • 依托单位:
PULSED ELECTROMAGNETIC FIELD EFFICACY IN REDUCING RHEUMATOID ARTHRITIS SYMPTOMS
  • 批准号:
    7606687
  • 项目类别:
  • 资助金额:
    $10.6万
  • 财政年份:
    2007
  • 负责人:
    CHERYL M BOURGUIGNON
  • 依托单位:
EFFECTS OF VALERIAN ON SLEEP DISTURBANCES IN PERSONS WITH ARTHRITIS
  • 批准号:
    7205498
  • 项目类别:
  • 资助金额:
    $0.71万
  • 财政年份:
    2005
  • 负责人:
    CHERYL M BOURGUIGNON
  • 依托单位:
PULSED ELECTROMAGNETIC FIELD EFFICACY IN REDUCING RHEUMATOID ARTHRITIS SYMPTOMS
  • 批准号:
    7205511
  • 项目类别:
  • 资助金额:
    $0.32万
  • 财政年份:
    2005
  • 负责人:
    CHERYL M BOURGUIGNON
  • 依托单位:
海外基金